LKFTLakefront Biotherapeutics NV

Healthcare
$29.74-13% 1Y

The financials

Lakefront Biotherapeutics NV by the numbers

For the full year FY2025, revenue was €1.11B (+304% year on year) and net income €321M.

Lakefront Biotherapeutics NV income statement, H2 2021 against the same quarter a year earlier
Income statementH2 2021Q2 2020Change
Revenuen/a€100Mn/a
Operating income−€74M−€88Mn/a
Net income−€48M−€115Mn/a

Biotechnology

Ranks #77 of 196 by RyuScore

Compare peers
STOK+3.3%
Stoke Therapeutics, Inc.
IOVA+9.6%
Iovance Biotherapeutics, Inc.
MESO+3.9%
Mesoblast Limited
VRDN+1.7%
Viridian Therapeutics, Inc.
SION0.00%
Sionna Therapeutics, Inc.
RAPP+2.9%
Rapport Therapeutics, Inc.